Abeona Therapeutics (ABEO) Amortizatization of Intangibles (2019 - 2026)

Abeona Therapeutics' (ABEO) quarterly Amortizatization of Intangibles came in at -$13000.0 in Q1 2026, up 97.14% year-on-year from -$6594.2 in Q1 2025, and up 98.11% quarter-over-quarter from -$687000.0 in Q4 2025.

Abeona Therapeutics (ABEO) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends

Abeona Therapeutics' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at -$13000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles rose 97.14% year-over-year to -$13000.0 in Q1 2026; TTM through Mar 2026 was -$447000.0, a 43.42% increase from a year earlier, with the FY2025 full-year figure at -$889000.0, down 222.1% from the prior year.
  • Amortizatization of Intangibles advanced to -$13000.0 in Q1 2026 per ABEO's latest filing, from -$687000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $227000.0 in Q4 2023 and bottomed at -$687000.0 in Q4 2025.
  • The 5-year median for Amortizatization of Intangibles is $29000.0 (2022), against an average of -$41470.6.
  • Biggest YoY gain for Amortizatization of Intangibles was 2257.14% in 2025; the steepest drop was 871.19% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $174000.0 in 2022, then surged by 30.46% to $227000.0 in 2023, then plunged by 197.8% to -$222000.0 in 2024, then tumbled by 209.46% to -$687000.0 in 2025, then jumped by 98.11% to -$13000.0 in 2026.
  • Per Business Quant, the three latest ABEO Amortizatization of Intangibles figures stand at -$13000.0 (Q1 2026), -$687000.0 (Q4 2025), and $88000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Abeona Therapeutics 347.09 Mn 178.82 Mn 6.02 Mn -13,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -13,000.00
Mar 31, 2026 -13,000.00
Dec 31, 2025 -687,000.00
Dec 31, 2025 -687,000.00
Sep 30, 2025 88,000.00
Sep 30, 2025 88,000.00
Jun 30, 2025 165,000.00
Jun 30, 2025 165,000.00
Mar 31, 2025 -455,000.00
Mar 31, 2025 -455,000.00
Dec 31, 2024 -222,000.00
Dec 31, 2024 -222,000.00
Sep 30, 2024 -120,000.00
Sep 30, 2024 -120,000.00
Jun 30, 2024 7,000.00
Jun 30, 2024 7,000.00
Mar 31, 2024 59,000.00
Mar 31, 2024 59,000.00
Dec 31, 2023 227,000.00
Dec 31, 2023 227,000.00